Test = vaccine
Sanofi vet Katherine Bowdish named CEO of PIC Therapeutics; As the world Terns: Liver disease biotech makes executive changes
Rapid screening tests that prioritize speed over accuracy could be key to ending the coronavirus pandemic
Verona Pharma to trial lung drug ensifentrine for COVID-19
Top U.S. health official says approval of COVID vaccines unlikely before November
Quidel’s Lyra Covid-19 Test Gets Nod For Sale In Canada; Shares Rise 6%
TSLA Stock Split Announced on Heels of AAPL Stock Split News
Oppenheimer: These 3 Penny Stocks Could Rally Over 100%
Is A COVID-19 Vaccine Our Best Hope?
Scientists identify hundreds of drug candidates to treat COVID-19
Mesoblast Tanks 35% Ahead Of FDA Meeting; Analyst Sees 85% Stock Upside
A COVID-19 vaccine needs the public's trust – and it's risky to cut corners on clinical trials, as Russia is
Novo-backed $61m fundraising helps F2G prep for antifungal launch
Potential Delay in Filing for Approval of Reata Pharmaceuticals’ FA Drug
Researchers create mask filtration effectiveness hierarchy
Goldman Sachs: These 3 Stocks Are Poised to Soar by at Least 30%
Inovio To Start Phase 2/3 Study Of Covid-19 Candidate In Sept.; Shares Drop 8%
I'm a COVID-19 long-hauler and an epidemiologist – here's how it feels when symptoms last for months
Novavax Rises 5% On Earnings; $2B Covid-19 Vaccine Funding
Ligand scoops up Pfenex for up to $516M, adding proteins to their antibody chickens and delivery tech
Gilead Submits New Drug Application With FDA For Remdesivir
PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined
Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease
Biogen Spikes 10% On FDA Fast Review For Potential Alzheimer Treatment
UPDATED: FDA hands out a quick OK for potential SMA blockbuster risdiplam, giving Genentech and Roche a chance to challenge rivals on the price
IoT and data science will boost foodtech in the post-pandemic era
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Needham: Time to Turn Bullish on These 2 Stocks
FDA takes the lead on defining essential under Trump's 'Buy American' executive order — as industry warns of supply chain disruption
Beware harm to federal health agencies